Realheart is a public company listed on Nasdaq First North Growth Market since December 17 2021, under the name (HEART).
The specific work we are doing with Hydrix is the development of the external control unit with the goal of creating a useful, portable controller that patients can feel comfortable with.
The Swedish innovation tradition has provided the world with medical technological inventions such as the heart and lung machine, the pacemaker and the dialysis machine. The next great innovation is Realheart’s artificial heart, Realheart TAH, a Swedish invention that not only saves lives but also creates a better quality of a prolonged life.